Log in to your Inderes Free account to see all free content on this page.

Vitrolife

105.30 SEK

-1.40%

Less than 1K followers

VITR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vitrolife

2019202020212022202320242025
Revenue1,480.11,245.61,680.83,234.03,512.03,609.03,440.0
growth-%-15.8 %34.9 %92.4 %8.6 %2.8 %-4.7 %
EBITDA530.2394.6454.1732.0-3,404.0962.0949.0
EBIT487.9370.0435.4654.0-3,589.0783.0-4,835.0
Profit before taxes492.7366.2460.0537.0-3,712.0674.0-4,886.0
Net income383.8287.9343.6394.0-3,851.0514.0-5,013.0
EPS3.532.642.972.91-28.443.79-37.01
Dividend1.050.800.800.851.001.101.10
Dividend ratio29.8 %30.3 %26.9 %29.2 %-3.5 %29.0 %-3.0 %
Login required

This content is only available for logged in users

Profitability and return on capital

2019202020212022202320242025
EBITDA-%35.8 %31.7 %27.0 %22.6 %-96.9 %26.7 %27.6 %
EBIT-%33.0 %29.7 %25.9 %20.2 %-102.2 %21.7 %-140.6 %
ROE21.4 %14.3 %2.2 %2.4 %-30.3 %3.8 %-63.5 %
ROI17.9 %12.5 %1.8 %1.9 %-23.6 %2.9 %-45.1 %
Login required

This content is only available for logged in users